OMED stock forecast
Our latest prediction for OncoMed Pharmaceuticals, Inc.'s stock price was made on the Oct. 10, 2018 when the stock price was at 2.04$.
In the short term (2weeks), OMED's stock price should outperform the market by 1.17%. During that period the price should oscillate between -9.27% and +16.11%.
In the medium term (3months), OMED's stock price should outperform the market by 11.53%. During that period the price should oscillate between -20.88% and +45.88%.Get email alerts
Create a solid portfolio with OMED
About OncoMed Pharmaceuticals, Inc.
Develops anti-cancer stem cell therapeutics
At the moment the company generates 55M USD in revenues.
On its last earning announcement, the company reported a profit of 0.16$ per share.
The book value per share is 1.13$
Three months stock forecastOct. 10, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|